FDA
approval
· 2019-10-24
FDA Approved: FROVATRIPTAN SUCCINATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
The FDA approved a supplemental application for frovatriptan succinate from Glenmark Pharmaceuticals Inc., USA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FROVATRIPTAN SUCCINATE (FROVATRIPTAN SUCCINATE)